The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial - PubMed

The 487-GEP identifies AD patients more likely to benefit from JAKi than Th2-targeted therapies.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov